A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 Years

NCT04421105 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Lysergic acid diethylamide (LSD) 5µg
DRUG: Lysergic acid diethylamide (LSD) 10µg
DRUG: Lysergic acid diethylamide (LSD)20 µg
DRUG: Placebo

Sponsor

Eleusis Therapeutics